Advertisement
Screener

BioCardia, Inc. (BCDA) Increase (Decrease) in Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

BioCardia, Inc. Increase (Decrease) in Deferred Revenue

BioCardia, Inc. (BCDA) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2025-03-26

  • BioCardia, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-12-31 was $0.00.
  • BioCardia, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was $0.00.
  • BioCardia, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-06-30 was $0.00.
  • BioCardia, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-03-31 was $0.00.
  • BioCardia, Inc. increase (decrease) in deferred revenue for fiscal 2024 was $0.00.
  • BioCardia, Inc. increase (decrease) in deferred revenue for fiscal 2023 was -$341.00K.
  • BioCardia, Inc. increase (decrease) in deferred revenue for fiscal 2022 was -$506.00K, a 408.54% decline from fiscal 2021.
  • BioCardia, Inc. increase (decrease) in deferred revenue for fiscal 2021 was $164.00K.
Period endIncrease (Decrease) in Deferred Revenue 3 monthIncrease (Decrease) in Deferred Revenue 6 monthIncrease (Decrease) in Deferred Revenue 9 monthIncrease (Decrease) in Deferred Revenue 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$0.00
derived: sum of 2 quarters · filed 2025-03-26
$0.00
derived: sum of 3 quarters · filed 2025-03-26
$0.00
10-K · filed 2025-03-26
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$0.00
derived: sum of 2 quarters · filed 2024-11-13
$0.00
10-Q · filed 2024-11-13
$0.00
derived: sum of 4 quarters · filed 2025-03-26
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$0.00
10-Q · filed 2024-08-13
$0.00
derived: sum of 3 quarters · filed 2025-03-26
-$333.00K
derived: sum of 4 quarters · filed 2025-03-26
2024-03-31$0.00
10-Q · filed 2024-05-14
$0.00
derived: sum of 2 quarters · filed 2025-03-26
-$333.00K
derived: sum of 3 quarters · filed 2025-03-26
-$340.00K
derived: sum of 4 quarters · filed 2025-03-26
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
-$333.00K
derived: sum of 2 quarters · filed 2025-03-26
-$340.00K
derived: sum of 3 quarters · filed 2025-03-26
-$341.00K
10-K · filed 2025-03-26
2023-09-30-$333.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$340.00K
derived: sum of 2 quarters · filed 2024-11-13
-$341.00K
10-Q · filed 2024-11-13
-$378.00K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$8.00K
10-Q · filed 2024-08-13
-$45.00K
derived: sum of 3 quarters · filed 2024-08-13
$333.00K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$1.00K
10-Q · filed 2024-05-14
-$38.00K
derived: sum of 2 quarters · filed 2024-05-14
$340.00K
derived: sum of 3 quarters · filed 2024-05-14
-$608.00K
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
$341.00K
derived: sum of 2 quarters · filed 2024-03-27
-$607.00K
derived: sum of 3 quarters · filed 2024-03-27
-$506.00K
10-K · filed 2024-03-27
2022-09-30$378.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$570.00K
derived: sum of 2 quarters · filed 2023-11-08
-$469.00K
10-Q · filed 2023-11-08
-$508.00K
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$948.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$847.00K
10-Q · filed 2023-08-09
-$886.00K
derived: sum of 3 quarters · filed 2023-08-09
-$1.42M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$101.00K
10-Q · filed 2023-05-10
$62.00K
derived: sum of 2 quarters · filed 2023-05-10
-$469.00K
derived: sum of 3 quarters · filed 2023-05-10
-$232.00K
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$39.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
-$570.00K
derived: sum of 2 quarters · filed 2023-03-29
-$333.00K
derived: sum of 3 quarters · filed 2023-03-29
$164.00K
10-K · filed 2023-03-29
2021-09-30-$531.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$294.00K
derived: sum of 2 quarters · filed 2022-11-09
$203.00K
10-Q · filed 2022-11-09
$203.00K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$237.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$734.00K
10-Q · filed 2022-08-10
$734.00K
derived: sum of 3 quarters · filed 2022-08-10
$728.00K
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$497.00K
10-Q · filed 2022-05-11
$497.00K
derived: sum of 2 quarters · filed 2022-05-11
$491.00K
derived: sum of 3 quarters · filed 2022-05-11
$491.00K
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
-$6.00K
derived: sum of 2 quarters · filed 2022-03-29
-$6.00K
derived: sum of 3 quarters · filed 2022-03-29
-$8.00K
10-K · filed 2022-03-29
2020-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$6.00K
derived: sum of 2 quarters · filed 2021-11-10
-$8.00K
10-Q · filed 2021-11-10
-$8.00K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$2.00K
10-Q · filed 2021-08-12
-$2.00K
derived: sum of 3 quarters · filed 2021-08-12
2020-03-31-$2.00K
10-Q · filed 2021-05-13
-$2.00K
derived: sum of 2 quarters · filed 2021-05-13
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$691.00K
10-K · filed 2021-03-30
2019-09-30$691.00K
10-Q · filed 2020-11-10
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09
$0.00
derived: sum of 2 quarters · filed 2020-04-09
-$30.00K
derived: sum of 3 quarters · filed 2020-04-09
-$65.00K
10-K · filed 2020-04-09
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$30.00K
derived: sum of 2 quarters · filed 2018-11-08
-$65.00K
10-Q · filed 2018-11-08
-$58.00K
derived: sum of 4 quarters · filed 2020-04-09
2018-06-30-$30.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$65.00K
10-Q · filed 2018-08-09
-$58.00K
derived: sum of 3 quarters · filed 2020-04-09
-$51.00K
derived: sum of 4 quarters · filed 2020-04-09
2018-03-31-$35.00K
10-Q · filed 2018-05-10
-$28.00K
derived: sum of 2 quarters · filed 2020-04-09
-$21.00K
derived: sum of 3 quarters · filed 2020-04-09
$60.00K
derived: sum of 4 quarters · filed 2020-04-09
2017-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09
$14.00K
derived: sum of 2 quarters · filed 2020-04-09
$95.00K
derived: sum of 3 quarters · filed 2020-04-09
$96.00K
10-K · filed 2020-04-09
2017-09-30$7.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$88.00K
derived: sum of 2 quarters · filed 2018-11-08
$89.00K
10-Q · filed 2018-11-08
$84.00K
derived: sum of 4 quarters · filed 2019-04-02
2017-06-30$81.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$82.00K
10-Q · filed 2018-08-09
$77.00K
derived: sum of 3 quarters · filed 2019-04-02
$77.00K
derived: sum of 4 quarters · filed 2019-04-02
2017-03-31$1.00K
10-Q · filed 2018-05-10
-$4.00K
derived: sum of 2 quarters · filed 2019-04-02
-$4.00K
derived: sum of 3 quarters · filed 2019-04-02
-$7.00K
derived: sum of 4 quarters · filed 2019-04-02
2016-12-31-$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02
-$5.00K
derived: sum of 2 quarters · filed 2019-04-02
-$8.00K
derived: sum of 3 quarters · filed 2019-04-02
$32.00K
10-K · filed 2019-04-02
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$3.00K
derived: sum of 2 quarters · filed 2017-11-09
$37.00K
10-Q · filed 2017-11-09
2016-06-30-$3.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$37.00K
10-Q · filed 2017-08-14
2016-03-31$40.00K
10-Q · filed 2017-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23